Doctolib Stock

doctolib.frHealthcare / Digital HealthFounded: 2013

Doctolib is an online healthcare platform that allows its users to access health professionals as well as manage their appointments and health documents. This company was founded in 2013 by Stanislas Niox-Chateau, Jessy Bernal, Steve Rjeily, Ivan Schneider, Marc Laurent, and Olivier Occelli and is headquartered in Levallois-Perret, France.

Register To Buy and Sell Shares

For more details on financing and valuation for Doctolib, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Doctolib’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Doctolib.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Stanislas Niox-Chateau
Co-Founder, Chief Executive Officer, Chairman & President
Philippe Vimard
Group Chief Operating Officer & Board Member
Jacques de la Bouillerie
Chief Operating Officer
Julien Meraud
Chief Strategy Officer & Chief Product Officer
Jessy Bernal
Co-Founder, Chief Technology Officer, Board Member & Solution Architect
Arthur Thirion
Chief Sales Officer & Managing Director
Agnès Bazin
Chief Development Officer
Matthieu Birach
Chief People Officer

Board Members

Antoine Freysz
Kerala Ventures
Ivan Schneider
Board Member
Philippe Botteri
Accel
Philippe Vimard
Board Member

Frequently Asked Questions About Doctolib’s Stock

plusminus
Can you buy Doctolib’s stock?
Doctolib is not publicly traded on NYSE or NASDAQ in the U.S. To buy Doctolib’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Doctolib’s stock?
Yes, you can sell stock of a private company like Doctolib. Forge can help you sell your Doctolib stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Doctolib’s stock price?
Doctolib is a privately held company and therefore does not have a public stock price. However, you may access Doctolib’s private market stock price with Forge Data.
plusminus
What is Doctolib’s stock ticker symbol?
Doctolib does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

France’s Doctolib acquires Amsterdam’s Siilo to help healthcare teams work together
Paris-based platform, Doctolib, which assists in scheduling appointments with specialist doctors, has acquired Amsterdam-based Siilo, a startup offering an instant messaging app for healthcare professionals. The acquisition will allow Doctolib to offer a comprehensive solution to care teams, facilitating better collaboration among healthcare providers and improved patient care.
Updated on: Apr 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.